Journal of Fish Diseases · 2018 · 28 citations · 34 references
Life SciencesFisheriesImmunologyHost-pathogen InteractionsImmunizationVaccinologyAdjuvant DesignFish ImmunologyInvertebrate ImmunityMarine Vaccine DevelopmentSubunit VaccinesVaccine PlatformsAquaculture VaccinesBacterial Fish VaccinesFish Antibody ResponseFish ImmunityFish Vaccine DevelopmentFusion Protein VaccinesVaccination-induced ImmunityVaccine Efficacy Evaluation
Abstract Vibriosis is a severe infection occurring in many commercially important marine fish species. In this study, vaccines containing Vibrio harveyi recombinant outer membrane protein K ( rO mpK), outer membrane protein U ( rO mpU) and rO mpK‐OmpU fusion protein in addition to the metabolizable Montanide TM ISA 763 A VG adjuvant were developed and evaluated in the orange‐spotted grouper. The results indicate that recombinant V. harveyi protein‐based vaccines resulted in a remarkably higher expression of IL ‐1β and IL ‐8 at 24 hr, and greater antibody production, as early as 2 weeks postimmunization. Notably, enhanced immune responses and significant protective efficacy against V. harveyi infections were observed in the fusion protein vaccine‐injected fishes with relative per cent survival value of 81.8%. Additionally, the rO mpK‐OmpU antisera presented a high bactericidal effect on not only V. harveyi , but also Vibrio parahaermolyticus and Vibrio alginolyticus . Our results demonstrated that the fusion protein rO mpK‐OmpU was an effective vaccine candidate that exhibited potentially great versatility for controlling vibrio infections.
34
Mark D. Fast, Stewart C. Johnson, Simon R. M. Jones · Fish & Shellfish Immunology · 2006 · 107 citations